Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00077974 · ClinicalTrials.gov registry record · Phase 2
A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 106
- Enrollment target
NCT00077974 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 106 participants.
The verdict
NCT00077974, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 106 participants
- Enrollment target
Study Summary
To assess the safety and efficacy of SU011248 in patients with metastatic, refractory renal cell carcinoma
Interventions
- DRUG SU011248
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2004-02 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00077974
The ClinicalTrials.gov registry entry for NCT00077974 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SU011248 is the first listed.
NCT00077974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00077974 about?
NCT00077974 is a clinical study titled "A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.". To assess the safety and efficacy of SU011248 in patients with metastatic, refractory renal cell carcinoma
What is the current status of trial NCT00077974?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 106 participants. The study started on 2004-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00077974?
The interventions under investigation include: SU011248 (DRUG).
Who is sponsoring clinical trial NCT00077974?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.